Ligand Pharmaceuticals (LGND) Goodwill (2010 - 2026)

Ligand Pharmaceuticals has disclosed Goodwill across 17 years of filings, most recently posting $101.5 million for Q1 2026.

• Goodwill for Q1 2026 came in at $101.5 million, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $101.5 million (changed 0.0% YoY), and the FY2025 annual result was $101.5 million, down 3.52% from the prior year.
• Goodwill came in at $101.5 million for Q1 2026 at Ligand Pharmaceuticals, roughly flat from $101.5 million in the prior quarter.
• In the past five years, Goodwill ranged from a high of $181.2 million in Q2 2022 to a low of $3.7 million in Q3 2023.
• The 5-year median for Goodwill is $105.2 million (2024), against an average of $95.6 million.
• Across the five-year window, Goodwill slumped 44.52% in 2022 and jumped 2737.69% in 2024, its largest moves.
• Ligand Pharmaceuticals' Goodwill stood at $181.2 million in 2022, then tumbled by 97.95% to $3.7 million in 2023, then surged by 2737.69% to $105.2 million in 2024, then slipped by 3.52% to $101.5 million in 2025, then changed by 0.0% to $101.5 million in 2026.
• The last three Goodwill figures came in at $101.5 million (Q1 2026), $101.5 million (Q4 2025), and $101.5 million (Q3 2025), per Business Quant data.